Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.
April 30, 2020
Early results of a COVID-19 treatment study being conducted in San Antonio shows a faster recovery time and fewer deaths for patients.
April 20, 2020
To understand and prevent COVID-19-induced heart disease, researchers will follow recovered patients.
April 17, 2020
This new type of ventilator made of inexpensive, widely available materials can help fill the demand created by the spread of COVID-19.
April 1, 2020
As laboratories across the country rush to find answers for the novel coronavirus, UT Health San Antonio is bringing a unique combination of expertise to bear on the crisis.